NeoGenomics announced a planned leadership transition as part of the Board of Directors’ long-term succession plan. President and Chief Operating Officer Warren Stone will become Chief Executive Officer on January 4, 2027. Current CEO Tony Zook will become Executive Chairman on that date.
The company reported preliminary, unaudited third-quarter revenue of approximately $209 million. Next-generation sequencing revenue increased roughly 28% year over year.
Based on the quarterly results, NeoGenomics expects to raise the midpoint of its full-year revenue guidance.